Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II–III Breast Cancer

Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group

(2010) Francesco Sardanelli et al.   EUROPEAN JOURNAL OF CANCER

Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial

(2010) Lindsay Turnbull et al.   LANCET

Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?

(2009) Gwen M. Grimsby et al.   AMERICAN JOURNAL OF SURGERY

Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment

(2009) H.-G. Moon et al.   ANNALS OF ONCOLOGY

Residual Breast Cancer Diagnosed by MRI in Patients Receiving Neoadjuvant Chemotherapy with and Without Bevacizumab

(2009) Shadfar Bahri et al.   ANNALS OF SURGICAL ONCOLOGY

Who Should Have Breast Magnetic Resonance Imaging Evaluation?

(2008) Susan Orel   JOURNAL OF CLINICAL ONCOLOGY

Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer

(2008) Nehmat Houssami et al.   JOURNAL OF CLINICAL ONCOLOGY